Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double‐blind, placebo‐controlled study.
Saved in:
| Title: | Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double‐blind, placebo‐controlled study. |
|---|---|
| Authors: | Takeshima, Takao1, Sakai, Fumihiko2, Hirata, Koichi3, Imai, Noboru4, Matsumori, Yasuhiko5, Yoshida, Ryuji6, Peng, Cheng7, Cheng, Sunfa8 sunfac@amgen.com, Mikol, Daniel D.8 |
| Source: | Headache: The Journal of Head & Face Pain. Jun2021, Vol. 61 Issue 6, p927-935. |
| Database: | SPORTDiscus with Full Text |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 00178748 |
|---|---|
| DOI: | 10.1111/head.14138 |
